Decoy Therapeutics Inc. (DCOY) Stock Ticker
DCOY right now
Market factors today
Unlock the full DCOY picture
About Decoy Therapeutics Inc.
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.
DCOY stock facts
| Ticker symbol | DCOY |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.6M |
| CEO | Frederick E. Pierce |
| Employees | 11 |
| Headquarters | Houston, TX, US |
| IPO date | 2015-01-29 |
| Website | decoytx.com |
What you can see for DCOY on Tickr
Live DCOY price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the DCOY report.
Rankings
FAQ
What is the ticker symbol for Decoy Therapeutics Inc.?
The ticker symbol for Decoy Therapeutics Inc. is DCOY, listed on the NASDAQ Capital Market.
What is DCOY?
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.